TABLE 2.

Baseline characteristics of patients from whom aortic valves were obtained.

	All patients (n = 23)	non-AS (n = 12)	AS (n = 11)	p-value
Age, years	66 ± 8	61 ± 7	71 ± 5	<0.001
Male, n (%)	20 (87.0%)	10 (83.3%)	10 (90.9%)	1.000
BMI, kg/m2	21.41 ± 1.80	22.24 ± 1.93	20.51 ± 1.17	0.018
Drinking, n (%)	4 (17.4%)	1 (8.3%)	3 (27.3%)	0.317
Smoking, n (%)	5 (21.7%)	2 (16.7%)	3 (27.3%)	0.640
Hypertension, n (%)	15 (65.2%)	8 (66.7%)	7 (63.6%)	1.000
CAD, n (%)	23 (100.0%)	12 (100.0%)	11 (100.0%)	1.000
DM, n (%)	3 (13.0%)	3 (25.0%)	0 (0.0%)	0.217
HbA1c,%	5.78 ± 0.54	6.00 ± 0.47	5.52 ± 0.52	0.030
Fasting glucose, mmol/L	5.25 ± 0.61	5.30 ± 0.82	5.20 ± 0.28	0.684
TG, mmol/L	1.26 (0.90–1.60)	1.40 (0.94–2.06)	1.15 (0.89–1.35)	0.347
TC, mmol/L	4.45 ± 1.06	4.32 ± 0.92	4.59 ± 1.23	0.542
HDL-C, mmol/L	1.00 ± 0.12	0.95 ± 0.13	1.06 ± 0.09	0.036
LDL-C, mmol/L	2.82 ± 0.80	2.82 ± 0.78	2.83 ± 0.85	0.975
Lp (a), g/L	0.11 (0.05–0.49)	0.07 (0.04–0.63)	0.20 (0.07–0.39)	0.26
BUN, mmol/L	6.10 (5.00–7.70)	6.15 (4.68–7.38)	6.10 (5.60–8.40)	0.608
Scr, μmol/L	80.39 ± 22.94	86.83 ± 25.07	73.36 ± 19.02	0.164
eGFR, mL/min/1.73 m2	84.15 ± 17.76	83.27 ± 22.03	85.12 ± 12.56	0.809
γ-GT, IU/L	30.48 ± 12.46	32.17 ± 14.28	28.64 ± 10.51	0.510
Ca, mmol/L	2.25 ± 0.13	2.24 ± 0.16	2.26 ± 0.08	0.793
P, mmol/L	1.07 ± 0.24	1.18 ± 0.16	0.94 ± 0.27	0.017
Statins, n (%)	5 (21.7%)	4 (33.3%)	1 (9.1%)	0.317
Antidiabetic therapy, n (%)	3 (13.0%)	3 (25.0%)	0 (0.0%)	0.217

Normally distributed variables: mean ± SD; skewed variables: median (interquartile range); categorical variable: n (%). For continuous variables, independent Student’s t-tests and Mann-Whitney U-tests were performed to assess differences. Differences in proportions were analyzed by 2 × 2 chi-square tests. Abbreviations as in Table 1.